Molbio Diagnostics

Molbio Diagnostics

Founded 2000 India

Verna, India 588 employees Venture round Total: $2.49B Biotechnology, Health Care +2

Molbio Diagnostics is a disruptor in the global healthcare landscape, aiming to revolutionize point-of-care diagnostics. Founded in 2000 and headquartered in India, the company's vision is centered on universalizing access to precise, rapid, and cost-effective healthcare technologies. Renowned for its WHO-endorsed Truenat® real-time PCR platform, Molbio is at the forefront of providing cutting-edge solutions for quality healthcare delivery at the last mile. The company's focus on decentralizing and democratizing diagnostics through advanced portable platforms has attracted significant attention in the industry. In its most recent funding round, Molbio secured a substantial $85.00M in Venture Round investment on 26 September 2022. The investment was led by Temasek Holdings and Motilal Oswal Private Equity, signaling strong support from prominent investors. Molbio's efforts empower remote, resource-poor settings worldwide to implement sophisticated diagnostics for a wide range of diseases, from infectious diseases like TB and hepatitis to non-communicable diseases such as breast cancer, sickle cell disease, and diabetes. The company's diverse portfolio of tests further showcases its commitment to advancing healthcare accessibility and efficiency. With its innovative approach and influential backers, Molbio is well-positioned to drive significant change in the healthcare industry.

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	$85.00M	2	Temasek Holdings, Motilal Oswal Private Equity	26 Sep 2022
Private Equity Round	INR2.40B	1	Motilal Oswal Private Equity	05 Mar 2020

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

$85.00M

Temasek Holdings, Motilal Oswal Private Equity

26 Sep 2022

Private Equity Round

INR2.40B

Motilal Oswal Private Equity

05 Mar 2020

FAQ About Molbio Diagnostics

Molbio is a disruptor in the global healthcare landscape, shifting existing paradigms in point-of-care diagnostics. With a vision focused on universalizing access to precise, rapid and cost-effective healthcare technologies, Molbio is at the forefront of providing cutting-edge solutions for quality...

Molbio Diagnostics was founded in 2000.

Molbio Diagnostics is headquartered in Verna, India.

Molbio Diagnostics operates in Biotechnology, Health Care, Manufacturing and Medical Devices. Its work centres on Molecular diagnostics, Real-time PCR, Lab equipment and Medical devices.

Molbio Diagnostics has approximately 588 employees.

Molbio Diagnostics has completed 2 funding rounds, raising a total of $2.49B. The latest funding stage is Venture round.

Top alternatives and competitors to Molbio Diagnostics include FRIZ Biochem GmbH, Paratus Diagnostics, True Diagnostics™, STAT-Dx, Ativa. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Molbio Diagnostics and FRIZ Biochem GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Molbio Diagnostics

Funding Rounds & Investors (2)

Molbio Diagnostics Alternatives & Competitors

FAQ About Molbio Diagnostics